Lv1
48 积分 2025-07-09 加入
First-in-Human Study on Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Escalating Doses of HEC88473, a Novel Dual GLP-1 and FGF21 Receptor Agonist in Healthy and Obese Chinese Subjects
1个月前
已完结
First-in-Human Study on Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Escalating Doses of HEC88473, a Novel Dual GLP-1 and FGF21 Receptor Agonist in Healthy and Obese Chinese Subjects
1个月前
已完结
Discovery of a potent and long-acting Xenopus GLP-1-based GLP-1/glucagon/Y2 receptor triple agonist
2个月前
已完结
The Impact of Liraglutide, a GLP-1 Receptor Agonist, on High Glucose-Induced Inflammation, Apoptosis, Oxidative Stress, and NLRP3 Signaling
2个月前
已完结
6-Azaspiro[2.5]octanes as small molecule agonists of the human glucagon-like peptide-1 receptor
3个月前
已完结
YN1548: A novel small-molecule agonist of human glucagon-like peptide-1 receptor for the treatment of type 2 diabetes mellitus and obesity
3个月前
已完结
Structural pharmacology and mechanisms of GLP-1R signaling
3个月前
已完结
YN1548: A novel small-molecule agonist of human glucagon-like peptide-1 receptor for the treatment of type 2 diabetes mellitus and obesity
3个月前
已完结
Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation
8个月前
已完结
皖公网安备34019202002308
